Trial · NCT02436096
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients With ≥30% Pain Improvement | Placebo SL Tablet | 58 | Participants | ||
| Proportion of Patients With ≥30% Pain Improvement | TNX-102 SL Tablet, 2.8 mg | 75 | Participants | ||
| Patient's Global Impression of Change (PGIC) | Placebo SL Tablet | 42 | Participants | ||
| Patient's Global Impression of Change (PGIC) | TNX-102 SL Tablet, 2.8 mg | 62 | Participants | ||
| Change From Baseline to Week 12 in the Fibromyalgia Impact Questionnaire - Revised (FIQR) Symptoms Domain Score | Placebo SL Tablet | -8.2 | Standard Error 1.13 | units on a scale | |
| Change From Baseline to Week 12 in the Fibromyalgia Impact Questionnaire - Revised (FIQR) Symptoms Domain Score | TNX-102 SL Tablet, 2.8 mg | -14.1 | Standard Error 1.14 | units on a scale | |
| Change From Baseline to Week 12 in the FIQR Function Domain Score | Placebo SL Tablet | -4.4 | Standard Error 1.15 | units on a scale | |
| Change From Baseline to Week 12 in the FIQR Function Domain Score | TNX-102 SL Tablet, 2.8 mg | -10.3 | Standard Error 1.16 | units on a scale | |
| Patient Reported Outcomes Measurement System (PROMIS) Sleep Disturbance | Placebo SL Tablet | -4.7 | Standard Error .53 | T-score | |
| Patient Reported Outcomes Measurement System (PROMIS) Sleep Disturbance | TNX-102 SL Tablet, 2.8 mg | -8.0 | Standard Error .54 | T-score | |
| Weekly Average of Daily Sleep Quality Diary | Placebo SL Tablet | -1.0 | Standard Error 0.11 | units on a scale | |
| Weekly Average of Daily Sleep Quality Diary | TNX-102 SL Tablet, 2.8 mg | -1.8 | Standard Error 0.11 | units on a scale | |
| Patient Reported Outcomes Measurement System (PROMIS) Fatigue | Placebo SL Tablet | -4.2 | Standard Error .47 | T-score | |
| Patient Reported Outcomes Measurement System (PROMIS) Fatigue | TNX-102 SL Tablet, 2.8 mg | -6.4 | Standard Error .47 | T-score | |
| Weekly Average of Daily Pain Diary | Placebo SL Tablet | -1.0 | Standard Error 0.11 | units on a scale | |
| Weekly Average of Daily Pain Diary | TNX-102 SL Tablet, 2.8 mg | -1.5 | Standard Error 0.11 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02436096/results